William Vainchenker
Inserm · 997 works · 45,695 citations · h-index 113
Top works
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
- Mutation in TET2 in Myeloid Cancers
- Megakaryocytic and erythrocytic lineages share specific transcription factors
- c-Mpl ligand is a humoral regulator of megakaryocytopoiesis
- TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
- Expression of platelet membrane glycoproteins and alpha‐granule proteins by a human erythroleukemia cell line (HEL).
- TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis
- Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis
- Two monoclonal antiplatelet antibodies as markers of human megakaryocyte maturation: immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in in vivo cells from normal and leukemic patients
- CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner
- Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera
- JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis
- A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38- progenitor cells in long-term cultures and semisolid assays
- Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
- Mutations of ASXL1 gene in myeloproliferative neoplasms
- Regulation of the expression of IL-6 in human monocytes.
- Expression of tal-1 and GATA-binding proteins during human hematopoiesis
- Growth of human megakaryocyte colonies in culture from fetal, neonatal, and adult peripheral blood cells: ultrastructural analysis.
- Inhibition of Insulin Receptor Binding by Phorbol Esters
- New mutations and pathogenesis of myeloproliferative neoplasms